Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16635791 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting T&B Depletion Non Malignant
Condition: Graft Versus Host Disease
Interventions: Biological: polyclonal antibody;   Drug: Rituximab;   Drug: Treosulfan;   Drug: Fludarabine;   Drug: Thiotepa;   Drug: Cyclosporine A;   Drug: Methotrexate

Indicates status has not been verified in more than two years